Lateral Femoral Cutaneous Nerve Cryoneurolysis for Meralgia Paresthetica: A Case Report.

Autor:	Pearson L; is the President of Metamorphosis Pain Management, Colorado Springs, Colorado; adjunct faculty in the Advanced Pain Management Fellowship at the University of South Florida, Tampa, Florida and Texas Christian University, Fort Worth, Texas. E-mail: anesthesia1@gmail.com., Schmelzer V; is the Chief Clinical Officer at Elevation Anesthesia and Director of Anesthesia at Southern Coos Hospital and Health Center, Bandon, Oregon. Email: reynoldsvicann@hotmail.com., Maye J; is a Professor and Program Director for the Advanced Pain Management Fellowship Program, University of South Florida, Tampa, Florida. Email: john.maye@usf.edu., Zhang SJ; is an Associate Professor at the Nurse Anesthesiology Program, College of Nursing, University of South Florida, Tampa, Florida; Adjunct Associate Professor at Samuel Merritt University, Oakland, California; and Adjunct Assistant Professor at University of California, San Francisco, San Francisco, California. E-mail: sarahjingyingz@usf.edu.
Jazyk:	angličtina
Zdroj:	AANA journal [AANA J] 2024 Feb; Vol. 92 (1), pp. 35-39.
Abstrakt:	Meralgia paresthetica (MP) is a disorder of lateral femoral cutaneous nerve mononeuropathy caused by entrapment or compression of the nerve. It is characterized by numbing, tingling, and burning pain in the lateral aspect of the thigh. The current treatments for MP include conventional medical management, peripheral nerve blocks, and surgical interventions. Some patients who suffer from MP can experience intractable pain and medical management of MP is often inadequate to provide satisfactory pain control. Although regional anesthesia provides excellent pain relief, the analgesic effects of peripheral nerve block are short-lived. Emerging evidence suggests that cryoneurolysis has a low-risk safety profile and can provide prolonged pain relief of superficial nerves when administered appropriately. We present a successful case of a patient with intractable neuropathic pain resulting from MP treated with cryoneurolysis therapy. The patient demonstrated immediate pain relief by 100% after the procedure followed by 80% and 60% pain reduction at 1-month and 3-months follow-up, respectively. Cryoneurolysis may be an alternative modality for patients who fail at conventional medical treatments of neuropathic pain. Competing Interests: Name: Lisa Pearson, DNAP, CRNA, NSPMc Contribution: This author made significant contributions to the conception, synthesis, writing, and final editing and approval of the manuscript to justify inclusion as an author. Disclosures: None. Name: Victoria Schmelzer, MS, CRNA, NSPMc Contribution: This author made significant contributions to the conception, synthesis, writing, and final editing and approval of the manuscript to justify inclusion as an author. Disclosures: None. Name: John Maye, PhD, CRNA Contribution: This author made significant contributions to the conception, synthesis, writing, and final editing and approval of the manuscript to justify inclusion as an author. Disclosures: None. Name: Sarah Jingying Zhang, PhD, CRNA Contribution: This author made significant contributions to the conception, synthesis, writing, and final editing and approval of the manuscript to justify inclusion as an author. This author is the corresponding author for this article. Disclosures: None. (Copyright © by the American Association of Nurse Anesthetists.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu PDF